Save time and jump to the most important pieces.
SC 13G/A - NVE CORP /NEW/ (0000724910) (Subject)
SC 13G/A - NVE CORP /NEW/ (0000724910) (Subject)
SC 13G - NVE CORP /NEW/ (0000724910) (Subject)
4 - NVE CORP /NEW/ (0000724910) (Issuer)
NVE Corporation (NASDAQ:NVEC) announced today financial results for the quarter and fiscal year ended March 31, 2025. Total revenue for the fourth quarter of fiscal 2025 increased 3% to $7.27 million from $7.08 million for the prior-year quarter. The increase was due to a 558% increase in contract research and development revenue, partially offset by a 1% decrease in product sales. Net income for the fourth quarter of fiscal 2025 increased 2% to $3.89 million, or $0.80 per diluted share, compared to $3.81 million, or $0.79 per diluted share, for the prior-year quarter. For fiscal 2025, total revenue decreased 13% to $25.9 million, compared to $29.8 million in the prior year. The decrease
NVE Corporation (NASDAQ:NVEC) announced that it plans to release its financial results for the quarter and fiscal year ended March 31, 2025 on Wednesday, May 7, 2025 after the close of the Nasdaq Regular Market. The company will hold its quarterly conference call later that day at 4:00 p.m. Central Time. The quarterly call will be webcast live in a listen-only mode through the Investor Events page of NVE's Website (www.nve.com). An archive of the call will also be available on NVE's Website. To dial into the conference call, parties should call 855-552-4463 inside the U.S., or 312-479-9427 and enter Meeting ID 7749 14 3539. Parties may request to ask questions on the call by dialing in or
NVE Corporation (NASDAQ:NVEC) announced today financial results for the quarter ended December 31, 2024. Total revenue for the third quarter of fiscal 2025 decreased 25% to $5.06 million from $6.76 million for the prior-year quarter. The decrease was due to a 22% decrease in product sales and a 74% decrease in contract research and development revenue. Net income for the third quarter of fiscal 2025 decreased 27% to $3.05 million, or $0.63 per diluted share, compared to $4.18 million, or $0.87 per share, for the prior-year quarter. For the first nine months of fiscal 2025, total revenue decreased 18% to $18.6 million from $22.7 million for the first nine months of the prior year. The de
4 - NVE CORP /NEW/ (0000724910) (Issuer)
4 - NVE CORP /NEW/ (0000724910) (Issuer)
4 - NVE CORP /NEW/ (0000724910) (Issuer)
NVE Corporation (NASDAQ:NVEC) announced today financial results for the quarter and fiscal year ended March 31, 2025. Total revenue for the fourth quarter of fiscal 2025 increased 3% to $7.27 million from $7.08 million for the prior-year quarter. The increase was due to a 558% increase in contract research and development revenue, partially offset by a 1% decrease in product sales. Net income for the fourth quarter of fiscal 2025 increased 2% to $3.89 million, or $0.80 per diluted share, compared to $3.81 million, or $0.79 per diluted share, for the prior-year quarter. For fiscal 2025, total revenue decreased 13% to $25.9 million, compared to $29.8 million in the prior year. The decrease
NVE Corporation (NASDAQ:NVEC) announced that it plans to release its financial results for the quarter and fiscal year ended March 31, 2025 on Wednesday, May 7, 2025 after the close of the Nasdaq Regular Market. The company will hold its quarterly conference call later that day at 4:00 p.m. Central Time. The quarterly call will be webcast live in a listen-only mode through the Investor Events page of NVE's Website (www.nve.com). An archive of the call will also be available on NVE's Website. To dial into the conference call, parties should call 855-552-4463 inside the U.S., or 312-479-9427 and enter Meeting ID 7749 14 3539. Parties may request to ask questions on the call by dialing in or
NVE Corporation (NASDAQ:NVEC) announced today financial results for the quarter ended December 31, 2024. Total revenue for the third quarter of fiscal 2025 decreased 25% to $5.06 million from $6.76 million for the prior-year quarter. The decrease was due to a 22% decrease in product sales and a 74% decrease in contract research and development revenue. Net income for the third quarter of fiscal 2025 decreased 27% to $3.05 million, or $0.63 per diluted share, compared to $4.18 million, or $0.87 per share, for the prior-year quarter. For the first nine months of fiscal 2025, total revenue decreased 18% to $18.6 million from $22.7 million for the first nine months of the prior year. The de
10-K - NVE CORP /NEW/ (0000724910) (Filer)
8-K - NVE CORP /NEW/ (0000724910) (Filer)
8-K/A - NVE CORP /NEW/ (0000724910) (Filer)